Genomic and clinical analyses of 2p24 and 12q13-q14 amplification in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. - Wikidata - awgldk - TriplyDB

Genomic and clinical analyses of 2p24 and 12q13-q14 amplification in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group.

Genomic and clinical analyses of 2p24 and 12q13-q14 amplification in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group.

http://www.wikidata.org/entity/Q41842448

about

Rhabdomyosarcoma: Advances in Molecular and Cellular Biology Analysis of molecular cytogenetic alteration in rhabdomyosarcoma by array comparative genomic hybridization Combined chemical-genetic approach identifies cytosolic HSP70 dependence in rhabdomyosarcoma Aberrant CDK4 amplification in refractory rhabdomyosarcoma as identified by genomic profiling Pediatric Rhabdomyosarcoma.Soft tissue sarcoma subtypes exhibit distinct patterns of acquired uniparental disomy.Genomic and clinical analysis of amplification of the 13q31 chromosomal region in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group.DAX-1 Expression in Pediatric Rhabdomyosarcomas: Another Immunohistochemical Marker Useful in the Diagnosis of Translocation Positive Alveolar Rhabdomyosarcoma.Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.New Treatments for Rhabdomyosarcoma: the Importance of Target Practice Multiple sites of highly amplified DNA sequences detected by molecular cytogenetic analysis in HS-RMS-2, a new pleomorphic rhabdomyosarcoma cell line Genomic and clinical analysis of fusion gene amplification in rhabdomyosarcoma: a report from the Children's Oncology Group.CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group report.Increased HOX C13 expression in metastatic melanoma progression.Pleiotropy between genetic markers of obesity and risk of prostate cancer.Hyperexpression of HOXC13, located in the 12q13 chromosomal region, in well‑differentiated and dedifferentiated human liposarcomas.Aberrant expression of posterior HOX genes in well differentiated histotypes of thyroid cancers Chromosomal and genetic imbalances in Chinese patients with rhabdomyosarcoma detected by high-resolution array comparative genomic hybridization.Molecular and cellular biology of rhabdomyosarcoma.Childhood rhabdomyosarcoma: new insight on biology and treatment.Myogenic tumors in children and adolescents.A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma.The genomic landscape of retinoblastoma: a review.Impact of fusion gene status versus histology on risk-stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials.Gene amplification during myogenic differentiation.Clinical utility gene card for: Alveolar rhabdomyosarcoma.Targeting the insulin-like growth factor pathway in rhabdomyosarcomas: rationale and future perspectives.Genetic heterogeneity in rhabdomyosarcoma revealed by SNP array analysis.FGFR1 and FGFR2 in fibrolamellar carcinoma.Characterization of genetic lesions in rhabdomyosarcoma using a high-density single nucleotide polymorphism array.Clinical and Cytogenetic Profiles of Rhabdomyosarcoma with Bone Marrow Involvement in Korean Children: A 15-Year Single-Institution Experience.The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells.DEAD box 1 (DDX1) expression predicts for local control and overall survival in early stage, node-negative breast cancer.A review of soft-tissue sarcomas: translation of biological advances into treatment measures.

P2860

Q26784207-9204AB5D-768C-4648-8330-174BABB17E72 Q28537996-38EE0CB6-A1C1-4895-B0C2-B53B88F27794 Q28830095-4DEBA0CB-75D3-4620-938C-0E9AF14C73F0 Q30563970-DF0B9ECB-B0FE-4969-8D5D-CB8C04BE9AB5 Q33842070-199A26C8-0271-4226-AA74-20F1D83CD6B7 Q34502885-AA74A6F9-1928-40CF-A02A-8D919E64D4CE Q34694293-DABCAB2C-CA40-4F8D-BECB-7B9B5D81BA4E Q35689673-6A6121B9-2105-4AEA-83C5-8246D908895C Q35711420-6EB72339-3F45-40B0-9B13-E82ECB7F6AB3 Q35729362-9089F6DD-99BA-433E-9BC5-1F1565FC6940 Q35832899-1164CD7E-D6D3-4E06-8BA3-8CE8842D28FF Q35947244-9C0BA9EA-0ED7-4C60-9A5F-3B6C8B4DC21B Q36093810-FE8D95A2-3013-4615-A86E-B3E4C61E705D Q36283044-BAD2D207-1B63-4BCB-A777-EC7A7B022D9B Q36338556-2530D1E9-CFD3-43A7-8ED5-AD70BC66FC72 Q37161336-BCB34D0E-E059-4FF6-A031-4D0B9907F349 Q37341266-83A866E3-35C9-410B-A39D-5F3DD2D34BDE Q37375359-4380751F-4B81-437D-AC83-1290B6C5F711 Q37587392-4BACD12B-475F-4FB2-AFD4-A16438765E03 Q37630588-89053BFB-6760-4205-B4E4-60BB6827A0A4 Q37785820-3058AFEE-662E-4ADC-B35E-FCFEE77D37D1 Q37993928-2B6296B8-D680-492D-81C2-444E633386FF Q38083828-32896FB3-799F-4956-9981-16C3452C73D4 Q38179069-7150C14B-534A-40D9-9E22-3A52DF5DB7FF Q38776314-B0FCCD74-DA9C-4BB4-A441-EC70A2C14769 Q38804212-E2918B47-BE2E-41ED-A539-E591BF779414 Q39701226-33B0A67A-0447-4E2D-B0BA-181D90DA965A Q39767891-862A6E07-7D67-48DD-8FB1-F70221C0BB9C Q40414512-C0405630-7530-4A9D-915F-D2B7111F30A5 Q40640497-C31036F4-DCFA-4890-B06C-7084CF1F0028 Q42823847-6BBA0BC1-8025-47FF-ABC9-B53D1A307A17 Q47353013-875E289F-B0F6-488F-A9E0-FD7F181BD042 Q51749352-AF6B1A3B-3BF9-42A8-9B58-F152DC08F2CB Q54574108-F3D49DAF-0D60-4B64-ACC5-1B1C8C064F3D Q55265062-2409DC59-D5FF-49F0-9A0E-03548930AD63

P2860

Genomic and clinical analyses of 2p24 and 12q13-q14 amplification in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group.

http://www.wikidata.org/entity/Q41842448

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Genomic and clinical analyses ...... the Children's Oncology Group.

@en

type

label

Genomic and clinical analyses ...... the Children's Oncology Group.

@en

prefLabel

Genomic and clinical analyses ...... the Children's Oncology Group.

@en

P1433

Q41842448-FBCCFED4-33C1-4624-8540-12C8F7810A1B

P1476

Q41842448-08EDE2D7-1D5C-4139-B105-D9F4FB6B624F

P2093

Q41842448-48301CCC-8E96-4DE7-95CA-5F0DFAF404C6

Q41842448-501519D0-91C7-457A-A2AE-6BEC1920C1E5

Q41842448-84768EA8-3F2E-4C83-B1A7-C1B41D5988B7

Q41842448-9A5AC4E8-3862-4063-9608-C386FA8228BF

Q41842448-B089021F-2D59-4D7E-9434-EBD5ABAD6C76

Q41842448-B4752574-57AE-402E-B2ED-C6F62E2F0E58

Q41842448-FBC132BC-EFE7-4D45-A53A-645C09D9D780

P2860

Q41842448-1BF379AA-E94A-450A-A614-957105D70ADE

Q41842448-1F563102-FDA6-49B2-B288-A462B1DFAD34

Q41842448-20A14E5A-14EB-457B-976F-BC435BBB65E5

Q41842448-654DA4E0-8956-4D26-93C0-F38F71965E8B

Q41842448-70B61141-BAE4-48F8-A616-71D00BDD378E

Q41842448-74C470D5-CE4A-4E49-9A85-55602185469E

Q41842448-753980C5-7193-4259-9B2C-B58B2C3B28B0

Q41842448-7844933C-8F59-48A6-B9EF-CD0BCF399F42

Q41842448-82D4CB61-5276-4C7F-98BD-D078A942720B

Q41842448-87765A39-6E29-49FD-9C3D-030A3F43ADE3

P304

Q41842448-9DEFF09C-B839-40C5-8640-4CA3F91DE14B

P31

Q41842448-9923F7D6-1ED3-4300-A94C-7A9E37FA51A9

P356

Q41842448-8083FCCD-34A2-463F-858E-397D4B0C8169

P433

Q41842448-15B22CDE-9ED6-42AD-8D76-71EF2B05FFB3

P478

Q41842448-79442826-BDDE-4CF9-AF2A-CA0A96FACABA

P577

Q41842448-20579A9B-26F7-467B-9559-68C19688AD29

P5875

Q41842448-6397EAE9-E1DB-4100-89F0-B4AFC9AC0556

P698

Q41842448-05E0D9E5-9F16-4E4A-8643-CF58D397D1E3

P932

Q41842448-E36CEF87-DAB0-4EBF-A223-5B4EB21C2460

P356

P1433

Genes, Chromosomes and Cancer

P1476

Genomic and clinical analyses ...... the Children's Oncology Group.

@en

P2093

Donna Gustafson

http://www.w3.org/2001/XMLSchema#string

Fenghai Duan

http://www.w3.org/2001/XMLSchema#string

Frederic G Barr

http://www.w3.org/2001/XMLSchema#string

Julie M Gastier-Foster

http://www.w3.org/2001/XMLSchema#string

Lynette M Smith

http://www.w3.org/2001/XMLSchema#string

Mandy Pitts

http://www.w3.org/2001/XMLSchema#string

Sue Hammond

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling

PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group

Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.

Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.

Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma.

MYCN in neuronal tumours.

DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies.

Examination of gene fusion status in archival samples of alveolar rhabdomyosarcoma entered on the Intergroup Rhabdomyosarcoma Study-III trial: a report from the Children's Oncology Group.

Mutations in Rb1 pathway-related genes are associated with poor prognosis in anaplastic astrocytomas.

Specificity, selection and significance of gene amplifications in cancer.

P304

661-672

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/GCC.20673

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24408062

http://www.w3.org/2001/XMLSchema#string

P698

19422036

http://www.w3.org/2001/XMLSchema#string

P932

2739400

http://www.w3.org/2001/XMLSchema#string